Gel could treat viral eye infection

Tampa-Sirion Therapeutics Inc. has made an exclusive licensing agreement with Laboratoires Thea of France for U.S. rights to develop and market a topical ophthalmic gel containing ganciclovir for treating certain viral and superficial eye infections.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.